PATIENT ENGAGEMENT

Patient Organization

Cooperation with patient organizations

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

 

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

Overview of cooperation with patient organizations in Europe in 2020

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2020.

 

Headquarters:

Bayer Company Bayer AG
Contract date 21.04.2020
Amount 150.000 EUR
Purpose of interaction Sponsorship of annual patient representative meeting 

 

Bayer Company Bayer AG
Contract date 27.04.2020
Amount 50.000 EUR
Purpose of interaction Sponsorship of World Scleroderma Day

 

Bayer Company Bayer AG
Contract date 29.06.2020
Amount 110.000 EUR
Purpose of interaction Support "Stroke Support Organisation Faculty Tool" (SSOFT)  maintenance and marketing and European Stroke Forum (focusing on treatment, management and care and support of stroke survivors after initial discharge from the hospital)

 

Bayer Company Bayer AG
Contract date 30.06.2020
Amount 100 EUR
Purpose of interaction Patient feedback session for a project

 

Bayer Company Bayer AG
Contract date 2020
Amount 5.000 EUR
Purpose of interaction Förderkreis-Mitgliedschaft 2020 im Kindernetzwerk e.V.

 

Bayer Company BCC AG
Contract date 04.09.2020
Amount 30.000 EUR
Purpose of interaction Annual Sponsorship of the International Diabetes Federation to support the organizations to fulfill its mission of being the global voice of people living with diabetes, promoting diabetes care, prevention and a cure worldwide.

 

Bayer Company BCC AG
Contract date 10.02.2020
Amount 400 CAD
Purpose of interaction Virtual Meeting EURETINA (Honoraria nAMD)

 

Bayer Company BCC AG
Contract date 10.02.2020
Amount 400 CAD
Purpose of interaction Virtual Meeting EURETINA (Honoraria Vision Academy)

 

Bayer Company BCC AG
Contract date 04.07.2020
Amount 11.600 CAD
Purpose of interaction nAMD Barometer Virtual Meeting Honoraria

 

Bayer Company BCC AG
Contract date 29.05.2020
Amount 800 CAD
Purpose of interaction Vision Academy SC Meeting Honoraria

 

Bayer Company BCC AG
Contract date 29.08.2020
Amount 800 CAD
Purpose of interaction Vision Academy Annual Meeting Honoraria

 

Bayer Company BCC AG
Contract date 25.10.2020
Amount 800 CAD
Purpose of interaction Vision Academy SC Meeting Honoraria

 

Bayer Company BCC AG
Contract date 11.10.2020
Amount 4.000 CAD
Purpose of interaction nAMD Barometer LC Activities 2020

 

Bayer Company BCC AG
Contract date 01.09.2020
Amount 50.000 USD
Purpose of interaction Annual sponsorship of the International Agency for Prevention of Blindness an to undertake work in advocating for the implementation of the Universal Eye Health and the Global Action Plan, support the development, roll out and uptake of the WHO’s ‘World Report on Vision’, continued engagement of the Sustainable Development Goals and provision of membership services.

 

Bayer Company BCC AG
Contract date 2020
Amount 52.500 EUR
Purpose of interaction EHC annual membership fees and congress sponsorship 2020
Bayer Company BCC AG
Contract date 18.12.2020
Amount 500 EUR
Purpose of interaction EU Patient Council 2020 / honorarium

 

Bayer Company BCC AG
Contract date 18.12.2020
Amount 374 EUR
Purpose of interaction EU Patient Council 2020 / honorarium

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.579,64 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.795,7 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 381,73 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.175,2 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 643,9 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 952,9 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.203,55 CHF
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Flight costs for invited attendees to participate in the meeting

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 4.894,09 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 5.099,39 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.768,23 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 3.536,46 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.665,58 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 3.331,16 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 2.000 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

Bayer Company BCC AG
Contract date 19-21.01.2020
Amount 1.562,93 EUR
Purpose of interaction Global Haemophilia Advocacy Leadership Summit in Lisbon, Hotel and F&B costs for invited attendees

 

 

Europe:

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna

Reports can be received from    

SC Bayer SRL 
Bayer Pharmaceuticals Division 
Sos. Pipera nr. 42., Sector 2 
NUSCO Tower fl. 1,16,17 
020112, Bucharest
Romania
 

Reports can be received from    

Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade
 

Reports can be received from    

Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana